Lv2
190 积分 2025-03-09 加入
3′UTR heterogeneity and cancer progression. Trends Cell Biol
14天前
已完结
The 2021 WHO Classification of Lung Tumors: impact of advances since 2015
14天前
已完结
Lung cancer
14天前
已完结
Non-small-cell lung cancer
14天前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
17天前
已完结
A statistical evaluation of toxicity study designs for the estimation of the benchmark dose in continuous endpoints
1个月前
已完结
Benchmark dose and the three Rs. Part II. Consequences for study design and animal use
1个月前
已完结
Benchmark dose and the three Rs. Part I. Getting more information from the same number of animals
1个月前
已完结
Benchmark dose and the three Rs. Part I. Getting more information from the same number of animals
1个月前
已关闭
Cellular stress and RNA splicing
4个月前
已完结
皖公网安备34019202002308
